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Abstract
The role that antioxidants play in the process of carcinogenesis has recently gained considerable attention. α-Lipoic acid, a naturally occurring 
disulfide molecule, is a powerful antioxidant that reportedly exerts beneficial effects in patients with advanced cancer by reducing the level of reactive
oxygen species and increasing glutathione peroxidase activity. In this study, we examined changes in the protein and mRNA expression associated
with cell proliferation and apoptosis in MDA-MB-231 breast cancer cultured in the presence of various concentrations (0, 250, 500, and 1000 μmol/L) 
of α-lipoic acid. The results revealed that α-lipoic acid inhibited the growth of breast cancer cells in a dose-independent manner (P< 0.05). Additionally,
ErbB2 and ErbB3 protein and mRNA expressions were significantly decreased in a dose-dependent manner in response to α-lipoic acid (P<0 . 0 5 ) .
Furthermore, the protein expression of phosphorylated Akt (p-Akt) levels and total Akt, and the mRNA expression of Akt were decreased dose-dependently 
in cells that were treated with α-lipoic acid (P< 0.05). Bcl-2 protein and mRNA expressions were also decreased in cells that were treated with 
α-lipoic acid (P< 0.05). However, Bax protein and mRNA expressions were increased in cells treated with α-lipoic acid (P< 0.05). Finally, caspase-3
activity was significantly increased in a dose-dependent manner in cells treated with α-lipoic acid (P < 0.05). In conclusion, we demonstrated that
α-lipoic acid inhibits cell proliferation and induces apoptosis in MDA-MB-231 breast cancer cell lines.
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Introduction2)
Breast cancer is a major health problem in women (Hortobagyi 
et al., 2005). In Korea, the incidence of breast cancer among 
women is second only to thyroid cancer, with a frequency of 
31.0 per 100,000 being observed in 2005 (Ministry of Health 
and Welfare and Family, 2008). Genetic factors are one of the 
main causes of breast cancer (Palacios et al., 2008). It is also 
known that there is a close relationship between the incidence 
of cancer and diet, and dietary factors can act as either risk or 
protective factors (Zhai et al., 2003). 
α-Lipoic acid was first separated from bovine livers in 1950 
and has since been found to occur naturally in extremely small 
amounts in many plants and animals (Reed et al., 1951). α-Lipoic 
acid acts as an important coenzyme for enzymes inside the 
mitochondria (Cameron et al., 1998), such as pyruvate 
dehydrogenase and α-ketoglutarate dehydrogenase; therefore, it 
has been treated as a vitamin-like substance (Gurer et al., 1999). 
α-Lipoic acid is easily absorbed and converted into the reduced 
form of dihydrolipoic acid in a variety of cellular tissues   (Packer, 
1998). α-Lipoic acid and dihydrolipoic acid mutually form a redox 
couple, which then acts as an antioxidant in water-soluble and 
fat-soluble environments. The anticancer effects of α-lipoic acid 
were found in various cancer types such as ovarian epithelial 
cancer cells (Vig-Varga et al., 2006) and B16F10 murine 
melanoma cells (Packer, 1998). And Wenzel et al. (2005) reported 
that  α-lipoic acid increases the level of active glutathione 
peroxidase in the body and reduces the oxidative stress, and 
therefore has a carcinostatic effect in cancer patients. But the 
anticancer effects of α-lipoic acid on breast cancer have not been 
fully understood. Accordingly, we investigated the effect of α
-lipoic acid on the proliferation and apoptosis of MDA-MB-231 
human breast cancer cells.
Materials and Methods
Materials and Reagents
α-Lipoic acid (Sigma, St. Louis, MO, USA) was dissolved in 
ethanol and diluted in cell culture medium. MDA-MB-231 cells 
were purchased from American Type Culture Collection (ATCC, 
Rockville, MD, USA). The following reagents and chemicals 
were obtained from the respective suppliers: Dulbecco’s modified 
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Eagle’s medium/Nutrient Mixture Ham’s F12 (DMEM/F12), 
streptomycin, and penicillin (Gibco/BRL); RIA-grade bovine 
serum albumin (BSA) and transferrin (Sigma); antibodies against 
ErbB2, ErbB3, Akt, p-Akt, Bcl-2, Bax, PY-20, and β-actin (Santa 
Cruz Biotechnology). All other reagents were obtained from 
Sigma (St. Louis, MO, USA). 
Cell culture
The MDA-MB-231 human breast cancer cell line was 
maintained in DMEM/F12 containing 100 mL/L fetal bovine 
serum (FBS) with 100,000 U/L penicillin and 100 mg/L 
streptomycin as described previously (Kim et al., 2005). Before 
MDA-MB-231 human breast cancer cells were treated with α
-lipoic acid, the cell monolayers were rinsed and starved of serum 
for 24 h by culture in DMEM/F12 supplemented with 5 mg/L 
transferrin, 1 g/L BSA, and 5 μg/L selenium (serum-free medium, 
SFM). After serum starvation, the medium was replaced with 
fresh SFM with the indicated concentrations of α-lipoic acid (0, 
25, 500, and 1,000 μmol/L). Cell proliferation was then estimated 
12, 24, and 48 h after the cells were exposed to α-lipoic acid 
using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT) assay, as described previously (Kim et al., 2005). 
Three independent experiments were done.
Western blotting analysis
Cell lysates were prepared as previously described (Lee et al., 
2004). The total cell lysates were resolved on a sodium 
dodecylsulfate 40-200 g/L polyacrylamide gel and then transferred 
to a polyvinylidene fluoride membrane (Millipore, Bedford, MA). 
Next, the blot was blocked for 1 h in 10 g/L BSA in TBS-T 
(20 mmol/L Tris-Cl, pH 7.5, 150 mmol/L NaCl, 1 g/L Tween 
20) or 50 g/L milk TBS-T, after which it was incubated for 1 
h with either anti-ErbB2, anti-ErbB3, anti-Akt, anti-p-Akt, 
anti-phospho-Tyr, anti-Bcl-2, or anti-Bax antibody. The blot was 
then incubated with antimouse or antirabbit HRP-conjugated 
antibody. Signals were detected by the enhanced chemiluminescence 
method using Super-Signal West Dura Extended Duration 
Substrate (Pierce, Rockford, IL). Finally, the relative abundance 
of each protein band was analyzed by scanning the exposed films 
densitometrically using the Image J Launcher (provided by 
NCBI). 
RNA expression (RT-PCR)
Total RNA was isolated using Tri-reagent (Sigma), and cDNA 
was synthesized using 2 μg of total RNA with SuperScript
TM 
II reverse transcriptase (Invitrogen). For amplification of cDNA, 
primers for ErbB2 (upstream primer, 5’-GTTTCCCAGATGA
GGAGGGCGCATGCC-3’; downstream primer, 5’-TTCTCCC 
CATCAGGGATCCAGATGCCC-3’ , annealing at 62℃ for 1 
min with 37 cycles), primers for ErbB3 (upstream primer, 5’-GG 
TGCTGGGCTTGCTTTT-3’; downstream primer, 5’-TTCTCC 
CCATCAGGGATCCAGATGCCC-3’, annealing at 57℃ for 1 
min with 27 cycles), primers for Akt (upstream primer, 5’-CA 
ACTTCTCTGTGGCGCAGTG-3’; downstream primer, 5’-GA 
CAGGTGGAAGAACAGCTCG-3’, annealing at 58℃ for 1 min 
with 30 cycles), primers for Bcl-2 (upstream primer, 5’-CGA 
CTTCGCCGAGATGTCCAGCCAG-3’; downstream primer, 5’- 
ACTTGTGGCCCAGATAGGCACCCAG-3’, annealing at 65℃ 
for 1 min with 35 cycles), primers for Bax (upstream primer, 
5’-CTGACATGTTTTCTGACGGC-3’; downstream primer, 5’- 
TCAGCCCATCTTCTTCCAGA-3’, annealing at 55℃ for 1 min 
with 32 cycles), and primers for β-actin (upstream primer, 
5’-GTTTGAGACCTTCAACACCCC-3’; downstream primer, 
5’-GTGGCCATCTCCTGCTCGAAGTC-3’, annealing at 60℃ 
for 1 min with 35 cycles) were used. The expression of human 
β-actin transcripts was examined as an internal control. The PCR 
products were separated on a 1% agarose gel and stained with 
ethidium bromide. Bands corresponding to each specific PCR 
product were quantified by densitometric scanning of the exposed 
film using the Bio-profile Bio-IL application (Vilber-Lourmat).
Activity of caspase-3 
The activity of caspase-3 was evaluated as previously described 
using a commercially available caspase-3 assay kit from Clontech 
Laboratories, Inc (Seo & Kim, 2006). Briefly, cells that were 
treated with α-lipoic acid were collected and suspended in 50 
μl of ice cold lysis buffer at a concentration of 2×10
6  cells. The 
cell lysates were then incubated on ice for 10 min, after which 
they were centrifuged at 1,500 rpm for 5 min. Next, the 
supernatant was placed in 96-well plates and incubated with 50 
μl 2× reaction buffer/DTT and caspase-3 colorimetric substrate 
DEVD-pNA for 1 h at 37℃. Finally, the absorbance at 405 nm 
was measured using a plate-reading micro plate reader. 
Statistical analysis 
Statistical analysis was conducted using the Statistical Analysis 
System (SAS Institute, Cary, NC). All data were expressed as 
the means ±standard deviations. Differences among groups were 
evaluated by analysis of variance (ANOVA), followed by Duncan's 
multiple range test when necessary. All data were tested at α=0.05. 
Results 
Inhibition of breast cancer cell proliferation by α-lipoic acid 
treatment
To evaluate the effects of α-lipoic acid on breast cancer cell 
proliferation, an MTT assay was conducted after cultivating the 
cells for 0, 12, 24, or 48 h in the presence of 0, 250, 500, and 
1,000 μmol/L α-lipoic acid. α-Lipoic acid had no effect on cell Mi Hee Na et al. 267
Fig. 1. Effect of α-lipoic acid on cell proliferation in MDA-MB-231 cells. 
MDA-MB-231 cells were plated at a density of 2.5×10
4 cells/ml in a 24 well plate 
w i t h  D M E M / F 1 2  s u p p l e m e n t e d  w i t h  1 0 %  F B S .  T h e  m o n o l a y e r s  w e r e  t h en 
s e r u m - s t a r v e d  w i t h  D M E M / F 1 2  s u p p l e m e n t e d  w i t h  5  μ g / m l  t r a n s f e r r in,  5  ng/ml 
selenium, and 1 mg/ml bovine serum albumin for 24 h. After serum starvation, the 
monolayers were incubated in serum - free medium with 0, 250, 500, or 1,000 μ
mol/L α-lipoic acid for 0, 12, 24, or 48 h Each bar represents  the mean ± S.D. 
of  three  independent  experiments.  Different  letters  indicate  significant  differences 
among  groups  at  α=0.05  as  determined  by  Duncan's  multiple  range t e s t .
Fig. 3. Effect of α-lipoic acid on Py-20 expression in MDA-MB-231 cells. 
MDA-MB-231 cells were plated in a 100 mm dish at a density 1×10
6 cells/dish 
w i t h  D M E M / F 1 2  s u p p l e m e n t e d  w i t h  1 0 %  F D S  f o r  4 8  h .  T h e  c e l l s  w e r e  then 
incubated in serum free medium for 24 h, after which they were incubated in the 
presence of α-lipoic acid at concentrations of 0, 250, 500 or 1,000 μmol/L for 
three days. Equal amounts of cell lysates (30 μg) were resolved  by  SDS-PAGE, 
transferred  to  a  membrane  and  probed  with  py-20.
Fig. 4. Effect of α-lipoic acid on ErbB2 and ErbB3 mRNA expression in 
MDA-MB-231 cells. MDA-MB-231 cells were treated with α-lipoic acid. Total RNA 
was isolated and RT-PCR was perform ed to investigate the m RNA expression of 
ErB2 (A) and ErB3 (B). (a) Photographs of ethidium bromide-stained gel, which were 
representative of three independent experiments, are shown. (b) Quantitative analysis 
of  RT-PCR.  Relative  abundance  of  each  band  was  estimated  by  densitomertric 
analysis. Each bar represents the mean ± S.D. calculated from three independent 
experiments. Comparisons among different concentrations of the α-lipoic acid that 
yielded statistically significant differences among groups at α=0.05 as determined 
by  Duncan's  multiple  range  test.
Fig. 2. Effect of α-lipoic acid on ErbB2 and ErbB3 protein expression in 
MDA-MB-231 cells. MDA-MB-231 cells were plated in a 100 mm dish at a density 
1×10
6 cells/dish with DMEM/F12 supplemented with 10% FDS for 48 h. The cells 
were then incubated in serum free medium for 24 h, after which  they were then 
incubated in the presence of α-lipoic acid at concentrations of 0, 250, 500, or 1,000 
μmol/L for three days. Equal amounts of cell lysates (30 μg) were then resolved 
by SDS-PAGE, transferred to a membrane and probed with ErbB2 (A) and ErbB 3
(B).  a)  Photographs  of  chemiluminiscent  detection  of  the  blots,  which  were 
representative  of  three  independent  experiments.  b)  Quantitative  analysis  of  the 
western  blots.  Each  bar  represents  the  mean ± S.D.  of  three  independent 
experiments.  Different  letters  indicate  significant  differences a m o n g  g r o u p s  a t  α
=0.05  as  determined  by  Duncan's  multiple  range  test.268 α-Lipoic acid and breast cancer cell proliferation
Fig. 5. Effect of α-lipoic acid on Akt, p-Akt protein expression and mRNA expression in MDA-MB-231 cells. For Proteins expression, MDA-MB-231 cells were plated 
in  a 1 0 0 m m  d ish  at a d en sity 1 × 10
6  cells/dish  with  DMEM/F12  supplemented  with  10%  FDS  for  48  h.  The cells were then  incubated in serum free medium for 24 h, 
after which they were incubated in the presence of α-lipoic acid at concentrations of 0, 250, 500 or 1,000 μmol/L for three days. Equal amounts of cell lysates (30 μg) 
were  then  resolved  by  SDS-PAGE,  transferred  to  a  membrane  and  pr o b e d  w it h  A k t  ( A )  a n d  p - A k t  ( B ) .  a )  P h o t o g r a p h s  o f  c h e m i lu m in iscent  detection  of  the  blots,  which 
were  representative  of  three independent  experiments. b)  Quantit a tiv e  a n a ly s is  o f t h e  w e s te rn  b lo t s . F o r R T -P C R , total  RNA  was  isolated  and  RT-PCR  was  performed  to 
investigate  the  mRNA  expression  Akt  (C).  (a)  Photographs  of  ethidium  bromide-stained  gel,  which  were  representative  of  three  independent  experiments,  are  shown.  (b) 
Quantitative analysis of RT-PCR. Relative abundance of each band was estimated by densitomertric analysis. Each bar represents the mean ± S.D. calculated from three 
independent experiments. Comparisons among different concentrations of the α-lipoic acid that yielded statistically significant differences among groups at α=0.05 as determined
by  Duncan's  multiple  range  test.
Fig. 6. Effect of α-lipoic acid on Bcl-2 and Bax protein expression in MDA-MB-231 cells. MDA-MB-231 cells were plated in a 100 mm dish at a density 1×10
6 cells/dish 
with  DMEM/F12 supplemented with 10%  FDS  for 48 h. The cells were then  incubated in serum free medium for 24 h,  after which  they  were incubated in the presence 
of  α-lipoic  acid  at  concentrations  of  0,  250,  500  or  1,000  μmol/L  for  three  days.  Equal  amounts  of  cell  lysates  (30  μg)  were  then  resolved  by  SDS-PAGE,  transferred 
to a membrane and probed with Bcl-2 (A) and Bax (B). a) Photographs of chemiluminiscent detection of the blots, which were representative of three independent experiments. 
b) Quantitative analysis of western blots. The Bcl-2/Bax ratio  was calculated (C). Each bar represents the mean ± S.D. of three  independent  experiments.  Different  letters 
indicate  a  significant  difference  among  groups  at  α=0.05  as  determined  by  Duncan's  multiple  range  test.
proliferation after 12 and 24 h of incubation. However, incubation 
with α-lipoic acid at a concentration of 250 μmol/L or higher 
for 48 h led to a significant decrease in cell proliferation (P
< 0.05) (Fig. 1). 
Inhibition of protein and mRNA expression associated with 
cancer cell proliferation by α-lipoic acid treatment
The protein expression of ErbB2  and ErbB3, which are epidermal 
growth factor receptors (EGFR) that control the cell growth signal 
of cancer cells, was decreased significantly in response to treatment 
with 250 μmol/L α-lipoic acid or higher (P < 0.05) (Fig. 2). In 
addition, when protein expression was observed using antibody 
Py20 to examine the tyrosine phosphorylation of these proteins, 
phosphorylated ErbB2  and ErbB3  were confirmed to be inhibited 
as the concentration of the α-lipoic acid treatment increased (P
< 0.05) (Fig. 3). And the mRNA expression of ErbB2  and ErbB3 
was decreased significantly in response to treatment with 500 
μmol/L α-lipoic acid or higher (ErbB2) and 250 μmol/L α-lipoic 
acid or higher (ErbB3) (P <0 . 0 5 )  ( F i g .  4 ) .
The expression of Akt protein, which receives the signal of 
the epidermal growth factor receptors to control cell proliferation, 
was found to be reduced significantly in response to treatment 
with 500 μmol/L  α-lipoic acid or higher, whereas the protein 
expression of the active form of Akt (p-Akt) was reduced 
significantly in response to treatment with concentrations of 250 
μmol/L and above (Fig. 5). The mRNA expression of Akt also 
was reduced significantly in response to treatment with 250 μ
mol/L  α-lipoic acid or higher (Fig. 5).Mi Hee Na et al. 269
Fig. 7. Effect of α-lipoic acid on Bcl-2 and Bax mRNA expression in 
MDA-MB-231 cells. MDA-MB-231 cells were treated with α-lipoic acid. Total RNA 
was isolated and RT-PCR was performed to investigate the m RNA expression of 
Bcl-2 (A) and Bax (B). (a) Photographs of ethidium bromide-stained gel, which were 
representative of three independent experiments, are shown. (b) Quantitative analysis 
of  RT-PCR.  Relative  abundance  of  each  band  was  estimated  by  densitomertric 
analysis. Each bar represents the mean ± S.D. calculated from three independent 
experiments. Comparisons among different concentrations of the α-lipoic acid that 
yielded statistically significant differences among groups at α=0.05 as determined 
by  Duncan's  multiple  range  test.
Fig. 8. Effect of α-lipoic acid on caspase-3 activities in MDA-MB-231 cells. Each 
bar represents the mean ± S.D. of three independent experiments. Different letters 
indicate significant differences among groups at α=0.05 as determined by Duncan's 
multiple  range  test. 
Induction of cancer cell apoptosis by α-lipoic acid treatment
When treated with α-lipoic acid at concentrations of 500 μ
mol/L and higher, the protein expression of Bcl-2 was decreased 
significantly, whereas the protein expression of Bax was 
increased significantly at concentration of 1,000 μmol/L α-lipoic 
acid (P < 0.05) (Fig. 6). The Bcl-2/Bax ratio, which was used 
as the index of cell apoptosis, was also significantly reduced in 
response to treatment with α-lipoic acid at concentrations of 500 
μmol/L and above (P < 0.05).
And mRNA expression of Bcl-2 was decreased significantly, 
whereas the mRNA expression of Bax was increased significantly 
in response to treatment with 1,000 μmol/L α-lipoic acid (P <
0.05) (Fig. 7).
Increase of caspase-3 activity
The activity of caspase-3 was significantly higher in cells that 
were treated with 1,000 μmol/L α-lipoic acid (P< 0.05) (Fig. 8).
Discussion
In the present study, we investigated the effects of α-lipoic 
acid on the proliferation and apoptosis of MDA-MB-231 human 
breast cancer cells.
α-Lipoic acid was found to significantly inhibit the proliferation 
of breast cancer cells (Fig. 2) in this study. Vig-Varga et al. 
(2006) reported that the proliferation of ovarian epithelial cancer 
cells separated from 8- week-old mice was significantly decreased 
by 75%, 85% and 100% in response to treatment with 10, 100, 
and 1000 μmol/L α-lipoic acid, respectively. Additionally, Pack 
et al. (2002) reported that treatment of Jurkat and CCRF-CEM 
human T lymphoma leukaemic cells with 0.01 mmol/L~4 mmol/L 
α-lipoic acid led to the dose-dependent inhibition of DNA 
replication and cell proliferation. Moreover, Packer (1998) 
reported that treatment of WM35 melanoma cells with 10~30 
μmol/L α-lipoic acid inhibited cell growth, while Jeoung (2006) 
reported that the survival rate of B16F10 murine melanoma cells 
treated with 0.1~7.5 mmol/L α-lipoic acid was decreased in a 
dose-dependent manner in response to treatment with α-lipoic 
acid at concentrations of 2.5 mmol/L and above. Taken together, 
these findings indicate that α-lipoic acid inhibits the proliferation 
of a wide variety of cancer cells.
The epidermal growth factor receptors (EGFR) play an 
important role in cancer cell proliferation and differentiation. 
EGFRs are composed of
  ErbB1/HER1, ErbB2/HER2, ErbB3/HER3, 
and ErbB4/HER4 (Bianco et al., 2007). The ErbB family receptors 
combine with an extracellular domain in homodimer and 
heterodimer forms (Perez-Nadales & Lloyd, 2004). Because 
ErbB3 cannot participate in intracellular reactions (Guy et al., 
1994), it forms a dimer with ErbB2 for signal transduction (Xue 
et al., 2006). When phosphorylation of this receptor dimer occurs, 270 α-Lipoic acid and breast cancer cell proliferation
it leads to activation of the endogenous receptor tyrosine kinase 
and the induction of autophosphorylation (Olayioye et al., 2000; 
Riese & Stern, 1998), which stimulates forward signal transduc-
tion, including the mitogene-activated protein (MAP) kinase and 
phospho-inositide 3-kinase (PI-3K) pathways. The expression of 
the ErbB2 gene is observed in breast cancer and plays a role 
in increasing the tyrosine phosphorylation of ErbB3 (Huang et 
al., 2000). Accordingly, excessive expression of ErbB2 is related 
to a poor prognosis for breast cancer (Kang et al., 2001). In 
this study, the protein and mRNA expression of ErbB2 and ErbB3 
was found to be significantly reduced in response to treatment 
with α-lipoic acid treatment (Fig. 2, 4), which indicates that α
-lipoic acid inhibits cancer cell proliferation via reduction in the 
excessive expression of EGFR s.
Akt is a serine/threonine kinase catalyzed by PI3K that inhibits 
cell apoptosis and promotes cell survival. Simbula et al., (2007) 
reported that treatment of FaO mice liver cancer cells with 500 
μmol/L  α-lipoic acid resulted in a reduction in the protein 
expression of the active form of Akt, p-Akt. Additionally, 
Laghero et al., (2007) found that treatment of HUVE cells with 
α-lipoic acid led to a reduction in the phosphorylation of the 
signal transduction substances Erk and Akt over time. In this 
experiment, we were also able to verify the inhibition of Akt 
expression by α-lipoic acid. Taken together, these results indicate 
that the inhibition of Akt protein and mRNA expression by α
-lipoic acid resulted in the reduction of cell proliferation observed 
in this study. 
There are several mechanisms involved in cancer cell apoptosis, 
including Bcl-2 family proteins and caspases (Alnemri, 1997; 
Marsh et al., 2005). Simbula et al. (2007) reported that α-lipoic 
acid increased the protein expression of p27 and p21, and that 
this signal in turn promoted the expression of Bax and induced 
the release of cytochrome C into the cytoplasm, which led to 
a subsequent increase in caspase-3 activity, thereby inducing cell 
apoptosis. Their results are consistent with the results of the present 
study. Sen et al. (1999) reported that treatment of blood cancer 
cells with α-lipoic acid led to an increase in caspase-3 activity. 
Moungjaroen et al. (2006) reported that α-lipoic acid treatment 
induced cell apoptosis of H460 lung cancer cells, and that this 
occurred via inhibition of the production of reactive oxygen species 
and increased expression of antioxidant enzymes such as 
superoxide dismutase by α-lipoic acid.
The results of our study indicate that α-lipoic acid exerts an 
inhibitory effect on cell proliferation via EGFRs and Akt signal 
transduction and induces cancer cell apoptosis in MDA-MB-231 
human breast cancer cells. Overall, these results indicate that α
-lipoic acid has the potential for use in the prevention of cancer. 
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